Peixoto A, Ferreira D, Miranda A, Relvas-Santos M, Freitas R, Veth T
iScience. 2025; 28(2):111758.
PMID: 39906564
PMC: 11791300.
DOI: 10.1016/j.isci.2025.111758.
Wei C, Zhang C, Zhou Y, Wang J, Jin Y
Int J Mol Sci. 2024; 25(16).
PMID: 39201351
PMC: 11354448.
DOI: 10.3390/ijms25168665.
Hu D, Kobayashi N, Ohki R
Cancers (Basel). 2024; 16(15).
PMID: 39123480
PMC: 11311387.
DOI: 10.3390/cancers16152753.
Tang H, Zhu D, Li W, Zhang G, Zhang H, Peng Q
Mol Neurobiol. 2024; 62(2):2212-2229.
PMID: 39090353
PMC: 11772456.
DOI: 10.1007/s12035-024-04387-y.
Ribatti D
Front Oncol. 2024; 14:1415601.
PMID: 39035739
PMC: 11257839.
DOI: 10.3389/fonc.2024.1415601.
A Novel Signature Based on Angiogenesis-Related Genes Predicts the Prognosis and Immunotherapy Response in HER2-Positive Breast Cancer.
Chen S, Cui W, Dong J, Chen W, Dong H, Zhao R
J Cancer. 2024; 15(14):4731-4748.
PMID: 39006091
PMC: 11242330.
DOI: 10.7150/jca.94120.
Cancer stem cells: advances in knowledge and implications for cancer therapy.
Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z
Signal Transduct Target Ther. 2024; 9(1):170.
PMID: 38965243
PMC: 11224386.
DOI: 10.1038/s41392-024-01851-y.
Tumor glucose metabolism and the T cell glycocalyx: implication for T cell function.
Schuurmans F, Wagemans K, Adema G, Cornelissen L
Front Immunol. 2024; 15:1409238.
PMID: 38881904
PMC: 11176483.
DOI: 10.3389/fimmu.2024.1409238.
Aberrant tumor vasculature. Facts and pitfalls.
Ribatti D
Front Pharmacol. 2024; 15:1384721.
PMID: 38576482
PMC: 10991687.
DOI: 10.3389/fphar.2024.1384721.
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease.
Pasala C, Sharma S, Roychowdhury T, Moroni E, Colombo G, Chiosis G
Biomolecules. 2024; 14(3).
PMID: 38540703
PMC: 10968129.
DOI: 10.3390/biom14030282.
Identification of prognostic models for glycosylation-related subtypes and tumor microenvironment infiltration characteristics in clear cell renal cell cancer.
Shen C, Zheng B, Chen Z, Zhang W, Chen X, Xu S
Heliyon. 2024; 10(6):e27710.
PMID: 38515689
PMC: 10955297.
DOI: 10.1016/j.heliyon.2024.e27710.
Endothelial Slc35a1 Deficiency Causes Loss of LSEC Identity and Exacerbates Neonatal Lipid Deposition in the Liver in Mice.
Zuo B, Yang F, Huang L, Han J, Li T, Ma Z
Cell Mol Gastroenterol Hepatol. 2024; 17(6):1039-1061.
PMID: 38467191
PMC: 11061248.
DOI: 10.1016/j.jcmgh.2024.03.002.
Endothelial cells in tumor microenvironment: insights and perspectives.
Leone P, Malerba E, Susca N, Favoino E, Perosa F, Brunori G
Front Immunol. 2024; 15:1367875.
PMID: 38426109
PMC: 10902062.
DOI: 10.3389/fimmu.2024.1367875.
Downregulation of ST6GAL2 Correlates to Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma.
Liu R, Yu X, Cao X, Wang X, Liang Y, Qi W
J Inflamm Res. 2024; 17:565-580.
PMID: 38318244
PMC: 10843983.
DOI: 10.2147/JIR.S437291.
Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
He M, Wang L, Yue Z, Feng C, Dai G, Jiang J
Aging (Albany NY). 2024; 16(2):1750-1766.
PMID: 38244579
PMC: 10866440.
DOI: 10.18632/aging.205455.
A glycosylation-related signature predicts survival in pancreatic cancer.
Hu H, He B, He M, Tao H, Li B
Aging (Albany NY). 2023; 15(23):13710-13737.
PMID: 38048216
PMC: 10756102.
DOI: 10.18632/aging.205258.
Identification of a Novel Prognostic Signature Based on N-Linked Glycosylation and Its Correlation with Immunotherapy Response in Hepatocellular Carcinoma.
Lin S, Cao Y, Zhu K, Yang C, Zhu X, Zhang H
J Hepatocell Carcinoma. 2023; 10:1749-1765.
PMID: 37841372
PMC: 10575065.
DOI: 10.2147/JHC.S417407.
SETDB1-mediated CD147-K71 di-methylation promotes cell apoptosis in non-small cell lung cancer.
Shi M, Wang Y, Shi Y, Tian R, Chen X, Zhang H
Genes Dis. 2023; 11(2):978-992.
PMID: 37692516
PMC: 10491884.
DOI: 10.1016/j.gendis.2023.02.015.
ROS impairs tumor vasculature normalization through an endocytosis effect of caveolae on extracellular SPARC.
Zhao Y, Yu J, Huang A, Yang Q, Li G, Yang Y
Cancer Cell Int. 2023; 23(1):152.
PMID: 37528424
PMC: 10394868.
DOI: 10.1186/s12935-023-03003-8.
Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism.
Jones R, Silva A, Ankenbauer K, Britain C, Chakraborty A, Brown J
Glycobiology. 2023; 33(8):626-636.
PMID: 37364046
PMC: 10560082.
DOI: 10.1093/glycob/cwad051.